health care costs

A recent cost-effectiveness analysis compared novel agents and chemotherapy for older Medicare patients with multiple myeloma, published in the Journal of Managed Care & Specialty Pharmacy (August...

A...

08/02/2017

Journal of Clinical Pathways

Research in Review

Financial Benefit of NGS Varies by Patient, Disease Type in Community Settings

06/01/2017

JCP Editors

Next-generation sequencing (NGS) may be economically beneficial for select patients with treated in the community oncology setting, but it should be carefully applied due to potential associated financial burdens,...

...

06/01/2017

Journal of Clinical Pathways

Interview

Payer Initiatives Drive Clinical Pathway Expansion

04/12/2017

JCP Editors

The future of clinical pathways largely depends on alternative payment models such as the Oncology Care Model sponsored by CMS, according to Edward Stepanski, PhD. ----- What inspired you to work in oncology? My...

The...

04/12/2017

Journal of Clinical Pathways

Research in Review

Melanoma Treatment Costs Vary by Insurance Type, Location

04/10/2017

JCP Editors

The treatment of advanced melanoma represents a significant burden to the health system, and differs by insurance type and geographic location, according to the results of a regional analysis. ----- Related...

The...

04/10/2017

Journal of Clinical Pathways

Research in Review

Study Identifies Steep Price Hikes for Older Cancer Drugs

10/17/2016

JCP Editors

The rising cost of cancer drugs continues to draw criticism from leading academic researchers, and threatens health care budgets. In a new study, researchers found that the price of older drugs increased more in a...

The...

10/17/2016

Journal of Clinical Pathways

Interview

Pathways for Cancer Survivors

10/12/2016

JCP Editors

Thanks to advances in medical research and more sophisticated methods of administration, cancer patients today are living longer than ever.1 Yet, while these advances have been universally celebrated by all health...

Thanks...

10/12/2016

Journal of Clinical Pathways

Research in Review

Out-of-Pocket Costs May Delay TKI Initiation in Patients With CML

10/10/2016

JCP Editors

The significant out-of-pocket costs cancer patients face before Medicare Insurance drug benefits kick in may delay initiation of tyrosine-kinase inhibitor (TKI) therapy for chronic myeloid leukemia (CML), according...

The...

10/10/2016

Journal of Clinical Pathways

Research in Review

Value-Driven Outcomes Program Reduces Costs and Improves Quality

09/26/2016

JCP Editors

An analytic tool that allocates clinical care costs and quality measures to individual patient encounters may help to enhance the quality of care delivered by physicians, according to research published in JAMA. As...

An...

09/26/2016

Journal of Clinical Pathways